Free Trial

Navidea Biopharmaceuticals (NAVB) Competitors

Navidea Biopharmaceuticals logo

NAVB vs. NKGN, SMFL, VRPX, SCPS, VAXX, TRVN, ARDS, EVLO, GNCAQ, and GNCA

Should you be buying Navidea Biopharmaceuticals stock or one of its competitors? The main competitors of Navidea Biopharmaceuticals include NKGen Biotech (NKGN), Smart for Life (SMFL), Virpax Pharmaceuticals (VRPX), Scopus BioPharma (SCPS), Vaxxinity (VAXX), Trevena (TRVN), Aridis Pharmaceuticals (ARDS), Evelo Biosciences (EVLO), Genocea Biosciences (GNCAQ), and Genocea Biosciences (GNCA). These companies are all part of the "pharmaceutical products" industry.

Navidea Biopharmaceuticals vs. Its Competitors

NKGen Biotech (NYSE:NKGN) and Navidea Biopharmaceuticals (NYSE:NAVB) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, risk, institutional ownership, earnings, profitability, dividends, valuation and analyst recommendations.

Navidea Biopharmaceuticals has higher revenue and earnings than NKGen Biotech.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NKGen BiotechN/AN/A-$82.94M-$1.72-0.01
Navidea Biopharmaceuticals$8.13K0.00-$15.18MN/AN/A

NKGen Biotech has a beta of 1.15, meaning that its share price is 15% more volatile than the S&P 500. Comparatively, Navidea Biopharmaceuticals has a beta of 1.76, meaning that its share price is 76% more volatile than the S&P 500.

Company Net Margins Return on Equity Return on Assets
NKGen BiotechN/A N/A -479.36%
Navidea Biopharmaceuticals N/A N/A N/A

76.2% of NKGen Biotech shares are owned by institutional investors. Comparatively, 0.0% of Navidea Biopharmaceuticals shares are owned by institutional investors. 10.4% of NKGen Biotech shares are owned by insiders. Comparatively, 43.7% of Navidea Biopharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, NKGen Biotech's average media sentiment score of 0.00 equaled Navidea Biopharmaceuticals'average media sentiment score.

Company Overall Sentiment
NKGen Biotech Neutral
Navidea Biopharmaceuticals Neutral

Summary

Navidea Biopharmaceuticals beats NKGen Biotech on 5 of the 6 factors compared between the two stocks.

Get Navidea Biopharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for NAVB and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NAVB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

NAVB vs. The Competition

MetricNavidea BiopharmaceuticalsDiagnostic substances IndustryMedical SectorNYSE Exchange
Market Cap$10K$26.58M$6.17B$21.91B
Dividend YieldN/AN/A5.73%3.62%
P/E RatioN/AN/A85.8230.12
Price / SalesN/A20.10579.16105.41
Price / CashN/AN/A37.4624.26
Price / BookN/AN/A12.694.69
Net Income-$15.18M-$21.09M$3.32B$1.01B

Navidea Biopharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NAVB
Navidea Biopharmaceuticals
N/AN/AN/AN/A$10K$8.13K0.0010High Trading Volume
NKGN
NKGen Biotech
N/A$0.00
+150.0%
N/A-91.3%$22KN/A0.00N/AGap Up
SMFL
Smart for Life
N/A$0.00
+25.0%
N/A-92.3%$18K$11.11M0.00110
VRPX
Virpax Pharmaceuticals
0.0784 of 5 stars
$0.01
flat
N/A-99.9%$14KN/A0.007Gap Down
SCPS
Scopus BioPharma
N/A$0.00
flat
N/A+0.0%$13KN/A0.009Gap Down
VAXX
Vaxxinity
N/A$0.00
-99.0%
N/A-97.5%$13KN/A0.0090
TRVN
Trevena
1.6601 of 5 stars
$0.01
flat
$5.00
+41,566.7%
-99.4%$12K$443K0.0040
ARDS
Aridis Pharmaceuticals
N/A$0.00
flat
N/AN/A$11KN/A0.0030Gap Up
High Trading Volume
EVLO
Evelo Biosciences
N/A$0.00
flat
N/A-33.3%$9KN/A0.00120News Coverage
Options Volume
GNCAQ
Genocea Biosciences
N/AN/AN/AN/A$6KN/A0.0070
GNCA
Genocea Biosciences
N/AN/AN/AN/A$6K$1.91M0.0070

Related Companies and Tools


This page (NYSE:NAVB) was last updated on 10/16/2025 by MarketBeat.com Staff
From Our Partners